On May 20, 2021, Merck announced V114, the company�s investigational 15-valent pneumococcal conjugate vaccine, met its primary immunogenicity…
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
On May 20, 2021, Pfizer and BioNTech announced an agreement with Turkeyï¾’s Ministry of Health to supply 60…
On May 18, 2021, GlaxoSmithKline and Medicago reported positive interim Phase 2 clinical trial safety and immunogenicity data…
On May 17, 2021, Oxford University and Oracle announced they had created a Global Pathogen Analysis System combining…
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
On May 13, 2021, CureVac announced together with its collaboration partner GSK, first preclinical data in a rat…
On May 13, 2021, University of Oxford researchers reported that Com-COV study data comparing mixed dosing schedules of…
On May 12, 2021, Moderna announced a new supply agreement with the government of Australia for 25 million…
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…
On May 7, 2021, the World Health Organization (WHO) listed the Sinopharm COVID-19 vaccine for emergency use, giving…
On May 7, 2021, Pfizer and BioNTech announced the initiation of a Biologics License Application (BLA) with the…
On May 6, 2021, Moderna announced a new supply agreement with the Swiss Federal Government for 7 million…
On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…
On May 6, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Novavax…
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…
On May 5, 2021, Pfizer and BioNTech announced that Health Canada had expanded the Interim Order authorization for…
On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…
On May 3, 2021, the World Health Organization (WHO) welcomed the Government of Swedenï¾’s announcement to share 1…
On May 3, 2021, Vaxart announced that new data obtained from its Phase I COVID-19 trial added to…
On May 3, 2021, Novavax announced that it had initiated a pediatric expansion of its Phase 3 clinical…
On May 3, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Moderna…
On Apr. 30, 2021, Moderna announced that the World Health Organization (WHO) had issued Emergency Use Listing (EUL)…
On Apr. 29, 2021, Lonza announced the expansion of its collaboration with Moderna to manufacture the drug substance…
On Apr. 29, 2021, the National Institutes of Health announced it was funding $29 million in additional grants…
On Apr. 29, 2021, Moderna announced it was making new funding commitments to increase supply at its owned…
On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…
On Apr. 28, 2021, VBI Vaccines announced that preclinical data of VBIï¾’s enveloped virus-like particle (eVLP) vaccine candidate,…
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…